CAS: 276702-15-9 - 6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide
Formula:C13H10Cl3N3O4S
- Synonyms:
- 332235
- Sb-332235
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
SB-332235 (6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide) REF: 4Z-U-065CAS: 276702-15-9 | - - - | To inquire | Tue 17 Dec 24 | |
SB 332235 REF: 3D-BLA70215CAS: 276702-15-9 | Min. 95% | To inquire | Tue 21 Jan 25 | |
SB-332235 REF: TM-T34544CAS: 276702-15-9 | - - - | 104.00 €~1,213.00 € | Tue 28 Jan 25 | |
SB 332235 REF: TR-S154665CAS: 276702-15-9 | - - - | - - - | Discontinued product |
SB-332235 (6-Chloro-3-[3-(2,3-dichlorophenyl)ureido]-2-hydroxybenzenesulfonamide)
CAS:276702-15-9
Formula:
C13H10Cl3N3O4S
Molecular weight:
410.67
Ref: 4Z-U-065
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
SB 332235
CAS:276702-15-9
SB 332235 is a small molecule that binds to the chemokine receptor CXCR2 and blocks …
Formula:
C13H10Cl3N3O4S
Purity:
Min. 95%
Molecular weight:
410.7 g/mol
Ref: 3D-BLA70215
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
SB-332235
CAS:276702-15-9
SB-332235 is an effective specific CXCR2 antagonist. And it is effectively inhibited CS-induced neutrophilia in …
Formula:
C13H10Cl3N3O4S
Color and Shape:
Solid
Molecular weight:
410.66
Ref: TM-T34544
1mg | 104.00 € | ||
5mg | 392.00 € | ||
10mg | 587.00 € | ||
25mg | 1,213.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
SB 332235
CAS:276702-15-9
Applications SB 332235 is a potent and selective CXCR2 antagonist. In vitro, SB 332235 inhibits …
Formula:
C13H10Cl3N3O4S
Color and Shape:
Pale Brown Solid
Molecular weight:
410.66
Ref: TR-S154665
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
2500µg | Discontinued | Request information |